India's new trade pact with the UK promised cheaper Scotch, but a customs row over bulk imports has Diageo and Pernod Ricard facing higher costs, legal uncertainty, and a test of market access.

Major pharmaceutical companies are urging the US Food and Drug Administration (FDA) to adopt a more flexible, risk-based approach in its guidance on testing container-closure systems (CCS) for drugs ...